Relapsed Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement

Drug	Drug Name	Drug Description
DB15102	Pemigatinib	A kinase inhibitor used to treat locally advanced or metastatic, unresectable cholangiocarcinoma in previously treated adult patients.

Drug	Drug Name	Target	Type
DB15102	Pemigatinib	Cytochrome P450 3A4	enzyme
DB15102	Pemigatinib	Fibroblast growth factor receptor 1	target
DB15102	Pemigatinib	Fibroblast growth factor receptor 2	target
DB15102	Pemigatinib	Fibroblast growth factor receptor 3	target
DB15102	Pemigatinib	Fibroblast growth factor receptor 4	target
DB15102	Pemigatinib	P-glycoprotein 1	transporter
DB15102	Pemigatinib	ATP-binding cassette sub-family G member 2	transporter
DB15102	Pemigatinib	Solute carrier family 22 member 2	transporter
DB15102	Pemigatinib	Multidrug and toxin extrusion protein 1	transporter

Drug	Drug Name	Phase	Status	Count